Related Experiment Video

Updated: Sep 23, 2026

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
08:02

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Published on: July 27, 2022

Phospholipase C-gamma1 in tumor progression

Alan Wells1, Jennifer Rubin Grandis

  • 1Pathology and Laboratory Service, Pittsburgh VAMC, Pennsylvania, USA. wellsa@msx.upmc.edu

Clinical & Experimental Metastasis
|July 15, 2003
PubMed

Insights

Most cancer deaths stem from metastasis. Phospholipase C-gamma 1 (PLCgamma) is identified as a key molecular switch regulating tumor cell migration, crucial for advanced cancer progression and potential therapeutic targeting.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cancer morbidity and mortality are primarily driven by tumor metastasis.
  • Current therapies are often ineffective against advanced-stage cancers with metastasis.
  • Targeting rate-limiting steps in tumor progression is crucial for developing new treatments.

Purpose of the Study:

  • To investigate molecular mechanisms underlying tumor cell invasion and metastasis.
  • To identify key signaling molecules that regulate tumor cell migration.
  • To explore the role of phospholipase C-gamma 1 (PLCgamma) in cancer progression.

Main Methods:

  • Analysis of signaling cascades involved in cell motility.
  • Investigating the function of phospholipase C-gamma 1 (PLCgamma) in tumor cell behavior.
  • Studying extracellular factor-stimulated cell migration in solid tumors.

Main Results:

  • Dysregulation of cell motility is a critical factor in tumor progression.
  • Phospholipase C-gamma 1 (PLCgamma) acts as a key molecular switch in signaling pathways.
  • PLCgamma plays a significant role in initiating tumor cell migration.

Conclusions:

  • Phospholipase C-gamma 1 (PLCgamma) is a critical regulator of tumor cell migration.
  • Targeting PLCgamma may offer a novel therapeutic strategy for advanced cancers.
  • Understanding PLCgamma's role is vital for developing effective anti-metastasis treatments.

More Related Videos

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

Related Concept Videos

IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...